In this study, we experimentally test the hypothesis of an aberrant, non-canonical, oxygen-independent HIF-1 activity as a prominent feature of the MDS pathobiology along with its potential as a therapeutic target. Here, HIF1A is linked to myelodysplastic syndrome.